Jaume Catala-Mora (Jaume Mora, J Mora)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 34

Top Topics

Tyrosine Kinase

Gene Expression

Virtual Reality

Top Venues

Cancer discovery

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Serena Mahnoor, Cristina Molnar, Diego Velázquez, Jose Reina, Salud Llamazares, Jan Peter Heinen, Jaume Catala-Mora, Cayetano Gonzalez
Human EWS-FLI protein levels and neomorphic functions show a complex, function-specific dose-response relationship in Drosophila . Open biology 14 (7) (2024)
Mònica Sánchez-Guixé, Ferran Muinos, Morena Pinheiro-Santin, Victor Gonzalez-Huici, Carlos J Rodriguez-Hernandez, Alexandra Avgustinova, Cinzia Lavarino, Nuria Lopez-Bigas, Jaume Catala-Mora, Núria López-Bigas
Origins of Second Malignancies in Children and Mutational Footprint of Chemotherapy in Normal Tissues. Cancer discovery 14 (6) (2024)
Mònica Sánchez-Guixé, Ferran Muinos, Morena Pinheiro-Santin, Victor Gonzalez-Huici, Carlos J Rodriguez-Hernandez, Alexandra Avgustinova, Cinzia Lavarino, Nuria Lopez-Bigas, Jaume Catala-Mora, Núria López-Bigas
Origins of Second Malignancies in Children and Mutational Footprint of Chemotherapy in Normal Tissues. Cancer discovery (2024)
Rubén Caballero, Albert Pasten, Carla Giménez, Raquel Rodríguez, Rosa María Carmona, Jaume Catala-Mora, Arnau Valls Esteve, Pamela Lustig, Federica Lombardini, Sol Balsells, Lucas Krauel
Beyond Needles: Pioneering Pediatric Care with Virtual Reality (VR) for TIVAD Access in Oncology. Cancers 16 (12) (2024)
Serena Mahnoor, Cristina Molnar, Diego Velázquez, Jose Reina, Salud Llamazares, Jan Peter Heinen, Jaume Catala-Mora, Cayetano Gonzalez
Human EWS-FLI protein levels and neomorphic functions show a complex, function-specific dose-response relationship in Drosophila . Open biology 14 (7) (2024)
Cristina Larrosa, Soraya Mico, Mónica Ramos, Sara Perez-Jaume, Mónica Sánchez, Alicia Castañeda, Moira Garraus, Jaume Catala-Mora
Radiation recall reaction induced by gemcitabine/docetaxel in children: A retrospective study on risk factors and outcomes. Pediatric blood & cancer (2024)
Rubén Caballero, Albert Pasten, Carla Giménez, Raquel Rodríguez, Rosa María Carmona, Jaume Catala-Mora, Arnau Valls Esteve, Pamela Lustig, Federica Lombardini, Sol Balsells, Lucas Krauel
Beyond Needles: Pioneering Pediatric Care with Virtual Reality (VR) for TIVAD Access in Oncology. Cancers 16 (12) (2024)
Aranzazu Villasante, Josep Corominas, Clara Alcon, Andrea García Lizarribar, Jaume Catala-Mora, Monica L Fanarraga, Josep Samitier
Identification of GB3 as a Novel Biomarker of Tumor-Derived Vasculature in Neuroblastoma Using a Stiffness-Based Model. Cancers 16 (5) (2024)
Serena Mahnoor, Cristina Molnar, Diego Velázquez, Jose Reina, Salud Llamazares, Jan Peter Heinen, Jaume Catala-Mora, Cayetano Gonzalez
Human EWS-FLI protein levels and neomorphic functions show a complex, function-specific dose-response relationship in Drosophila . Open biology 14 (7) (2024)
Mònica Sánchez-Guixé, Ferran Muinos, Morena Pinheiro-Santin, Victor Gonzalez-Huici, Carlos J Rodriguez-Hernandez, Alexandra Avgustinova, Cinzia Lavarino, Nuria Lopez-Bigas, Jaume Catala-Mora, Núria López-Bigas
Origins of Second Malignancies in Children and Mutational Footprint of Chemotherapy in Normal Tissues. Cancer discovery 14 (6) (2024)
Cristina Larrosa, Soraya Mico, Mónica Ramos, Sara Perez-Jaume, Mónica Sánchez, Alicia Castañeda, Moira Garraus, Jaume Catala-Mora
Radiation recall reaction induced by gemcitabine/docetaxel in children: A retrospective study on risk factors and outcomes. Pediatric blood & cancer 71 (10) (2024)
Aranzazu Villasante, Josep Corominas, Clara Alcon, Andrea García Lizarribar, Jaume Catala-Mora, Monica L Fanarraga, Josep Samitier
Identification of GB3 as a Novel Biomarker of Tumor-Derived Vasculature in Neuroblastoma Using a Stiffness-Based Model. Cancers 16 (5) (2024)
Mònica Sánchez-Guixé, Ferran Muinos, Morena Pinheiro-Santin, Victor Gonzalez-Huici, Carlos J Rodriguez-Hernandez, Alexandra Avgustinova, Cinzia Lavarino, Nuria Lopez-Bigas, Jaume Catala-Mora, Núria López-Bigas
Origins of Second Malignancies in Children and Mutational Footprint of Chemotherapy in Normal Tissues. Cancer discovery (2024)
Mònica Sánchez-Guixé, Ferran Muinos, Morena Pinheiro-Santin, Victor Gonzalez-Huici, Carlos J Rodriguez-Hernandez, Alexandra Avgustinova, Cinzia Lavarino, Nuria Lopez-Bigas, Jaume Catala-Mora, Núria López-Bigas
Origins of Second Malignancies in Children and Mutational Footprint of Chemotherapy in Normal Tissues. Cancer discovery 14 (6) (2024)
Mònica Sánchez-Guixé, Ferran Muinos, Morena Pinheiro-Santin, Victor Gonzalez-Huici, Carlos J Rodriguez-Hernandez, Alexandra Avgustinova, Cinzia Lavarino, Nuria Lopez-Bigas, Jaume Catala-Mora, Núria López-Bigas
Origins of Second Malignancies in Children and Mutational Footprint of Chemotherapy in Normal Tissues. Cancer discovery 14 (6) (2024)
Mònica Sánchez-Guixé, Ferran Muinos, Morena Pinheiro-Santin, Victor Gonzalez-Huici, Carlos J Rodriguez-Hernandez, Alexandra Avgustinova, Cinzia Lavarino, Nuria Lopez-Bigas, Jaume Catala-Mora, Núria López-Bigas
Origins of Second Malignancies in Children and Mutational Footprint of Chemotherapy in Normal Tissues. Cancer discovery 14 (6) (2024)
Jaume Catala-Mora, Shakeel Modak, Joyce Kinsey, Carolyn E Ragsdale, Hillard M Lazarus
GM-CSF, G-CSF or no cytokine therapy with anti-GD2 immunotherapy for high-risk neuroblastoma. International journal of cancer (2023)
Lin Xu, Joshua L Pierce, Angelica Sanchez, Kenneth S Chen, Abhay A Shukla, Nicholas J Fustino, Sarai H Stuart, Aditya Bagrodia, Xue Xiao, Lei Guo, Mark D Krailo, Furqan Shaikh, Deborah F Billmire, Farzana D Pashankar, Jessica Bestrashniy, J Wolter Oosterhuis, Ad J M Gillis, Yang Xie, Lisa Teot, Jaume Catala-Mora, Jenny N Poynter, Dinesh Rakheja, Leendert H J Looijenga, Bruce W Draper, A Lindsay Frazier, James F Amatruda
Integrated genomic analysis reveals aberrations in WNT signaling in germ cell tumors of childhood and adolescence. Nature communications 14 (1) (2023)
Lin Xu, Joshua L Pierce, Angelica Sanchez, Kenneth S Chen, Abhay A Shukla, Nicholas J Fustino, Sarai H Stuart, Aditya Bagrodia, Xue Xiao, Lei Guo, Mark D Krailo, Furqan Shaikh, Deborah F Billmire, Farzana D Pashankar, Jessica Bestrashniy, J Wolter Oosterhuis, Ad J M Gillis, Yang Xie, Lisa Teot, Jaume Catala-Mora, Jenny N Poynter, Dinesh Rakheja, Leendert H J Looijenga, Bruce W Draper, A Lindsay Frazier, James F Amatruda
Integrated genomic analysis reveals aberrations in WNT signaling in germ cell tumors of childhood and adolescence. Nature communications 14 (1) (2023)
Jaume Catala-Mora, Shakeel Modak, Joyce Kinsey, Carolyn E Ragsdale, Hillard M Lazarus
GM-CSF, G-CSF or no cytokine therapy with anti-GD2 immunotherapy for high-risk neuroblastoma. International journal of cancer 154 (8) (2023)
Lin Xu, Joshua L Pierce, Angelica Sanchez, Kenneth S Chen, Abhay A Shukla, Nicholas J Fustino, Sarai H Stuart, Aditya Bagrodia, Xue Xiao, Lei Guo, Mark D Krailo, Furqan Shaikh, Deborah F Billmire, Farzana D Pashankar, Jessica Bestrashniy, J Wolter Oosterhuis, Ad J M Gillis, Yang Xie, Lisa Teot, Jaume Catala-Mora, Jenny N Poynter, Dinesh Rakheja, Leendert H J Looijenga, Bruce W Draper, A Lindsay Frazier, James F Amatruda
Integrated genomic analysis reveals aberrations in WNT signaling in germ cell tumors of childhood and adolescence. Nature communications 14 (1) (2023)
Lin Xu, Joshua L Pierce, Angelica Sanchez, Kenneth S Chen, Abhay A Shukla, Nicholas J Fustino, Sarai H Stuart, Aditya Bagrodia, Xue Xiao, Lei Guo, Mark D Krailo, Furqan Shaikh, Deborah F Billmire, Farzana D Pashankar, Jessica Bestrashniy, J Wolter Oosterhuis, Ad J M Gillis, Yang Xie, Lisa Teot, Jaume Catala-Mora, Jenny N Poynter, Dinesh Rakheja, Leendert H J Looijenga, Bruce W Draper, A Lindsay Frazier, James F Amatruda
Integrated genomic analysis reveals aberrations in WNT signaling in germ cell tumors of childhood and adolescence. Nature communications 14 (1) (2023)
Jaume Catala-Mora, Shakeel Modak, Joyce Kinsey, Carolyn E Ragsdale, Hillard M Lazarus
GM-CSF, G-CSF or no cytokine therapy with anti-GD2 immunotherapy for high-risk neuroblastoma. International journal of cancer 154 (8) (2023)
Piotr Kobialka, Helena Sabata, Odena Vilalta, Leonor Gouveia, Ana Angulo-Urarte, Laia Muixí, Jasmina Zanoncello, Oscar Muñoz-Aznar, Nagore G Olaciregui, Lucia Fanlo, Anna Esteve-Codina, Cinzia Lavarino, Biola M Javierre, Veronica Celis, Carlota Rovira, Susana López-Fernández, Eulalia Baselga, Jaume Catala-Mora, Sandra D Castillo, Mariona Graupera
The onset of PI3K-related vascular malformations occurs during angiogenesis and is prevented by the AKT inhibitor miransertib. EMBO molecular medicine 14 (7) (2022)
Eshini Panditharatna, Joana G Marques, Tingjian Wang, Maria C Trissal, Ilon Liu, Li Jiang, Alexander Beck, Andrew Groves, Neekesh V Dharia, Deyao Li, Samantha E Hoffman, Guillaume Kugener, McKenzie L Shaw, Hafsa M Mire, Olivia A Hack, Joshua M Dempster, Caleb A Lareau, Lingling Dai, Logan H Sigua, Michael A Quezada, Ann-Catherine J Stanton, Meghan Wyatt, Zohra Kalani, Amy Goodale, Francisca Vazquez, Frederica Piccioni, John G Doench, David E Root, Jamie N Anastas, Kristen L Jones, Amy Saur Conway, Sylwia A Stopka, Michael S Regan, Yu Liang, Hyuk-Soo Seo, Kijun Song, Puspalata Bashyal, William P Jerome, Nathan D Mathewson, Sirano Dhe-Paganon, Mario L Suvà, Angel Montero Carcaboso, Cinzia Lavarino, Jaume Catala-Mora, Quang-De Nguyen, Keith L Ligon, Yang Shi, Sameer Agnihotri, Nathalie Y R Agar, Kimberly Stegmaier, Charles D Stiles, Michelle Monje, Todd R Golub, Jun Qi, Mariella G Filbin
BAF Complex Maintains Glioma Stem Cells in Pediatric H3K27M Glioma. Cancer discovery 12 (12) (2022)
Sara Sánchez-Molina, Elisabet Figuerola-Bou, Víctor Sánchez-Margalet, Luis de la Cruz Merino, Jaume Catala-Mora, Enrique de Álava, Daniel José García-Domínguez, Lourdes Hontecillas-Prieto
Ewing Sarcoma Meets Epigenetics, Immunology and Nanomedicine: Moving Forward into Novel Therapeutic Strategies. Cancers 14 (21) (2022)
Jaume Catala-Mora
Autologous Stem-Cell Transplantation for High-Risk Neuroblastoma: Historical and Critical Review. Cancers 14 (11) (2022)
Daniel José García-Domínguez, Nabil Hajji, Sara Sánchez-Molina, Elisabet Figuerola-Bou, Rocío M de Pablos, Ana M Espinosa-Oliva, Eduardo Andrés León, Laura Carmen Terrón-Camero, Rocío Flores-Campos, Guillem Pascual-Pasto, María José Robles, Isidro Machado, Antonio Llombart-Bosch, Giovanna Magagnoli, Katia Scotlandi, Angel Montero Carcaboso, Jaume Catala-Mora, Enrique de Álava, Lourdes Hontecillas-Prieto
Selective inhibition of HDAC6 regulates expression of the oncogenic driver EWSR1-FLI1 through the EWSR1 promoter in Ewing sarcoma. Oncogene 40 (39) (2021)
Jing Liu, Daniela Ottaviani, Meriem Sefta, Céline Desbrousses, Elodie Chapeaublanc, Rosario Aschero, Nanor Sirab, Fabiana Lubieniecki, Gabriela Lamas, Laurie Tonon, Catherine Dehainault, Clément Hua, Paul Fréneaux, Sacha Reichman, Narjesse Karboul, Anne Biton, Liliana Mirabal-Ortega, Magalie Larcher, Céline Brulard, Sandrine Arrufat, André Nicolas, Nabila Elarouci, Tatiana Popova, Fariba Nemati, Didier Decaudin, David Gentien, Sylvain Baulande, Odette Mariani, Florent Dufour, Sylvain Guibert, Céline Vallot, Livia Lumbroso-Le Rouic, Alexandre Matet, Laurence Desjardins, Guillem Pascual-Pasto, Mariona Suñol, Jaume Catala-Mora, Genoveva Correa Llano, Jérôme Couturier, Emmanuel Barillot, Paula S Schaiquevich, Marion Gauthier-Villars, Dominique Stoppat-Lyonnet, Lisa Golmard, Claude Houdayer, Hervé J Brisse, Isabelle Bernard-Pierrot, Eric Letouzé, Alain Viari, Simon Saule, Xavier Sastre-Garau, François Doz, Angel Montero Carcaboso, Nathalie Cassoux, Celio Pouponnot, Olivier Goureau, Guillermo L Chantada, Aurélien de Reyniès, Isabelle Aerts, François Radvanyi
A high-risk retinoblastoma subtype with stemness features, dedifferentiated cone states and neuronal/ganglion cell gene expression. Nature communications 12 (1) (2021)
Marta Martinez-Lage, Raul Torres-Ruíz, Pilar Puig-Serra, P Moreno-Gaona, M C Martin, F J Moya, Oscar Quintana-Bustamante, Susana Garcia-Silva, Angel Montero Carcaboso, P Petazzi, C Bueno, Jaume Catala-Mora, Hector Peinado, José Carlos Segovia, P Menendez, Sandra Rodríguez-Perales
In vivo CRISPR/Cas9 targeting of fusion oncogenes for selective elimination of cancer cells. Nature communications 11 (1) (2020)
Brigitte Royer-Pokora, Maike Anna Busch, Sarah Tenbusch, Mathias Schmidt, Manfred Beier, Andrew D Woods, Holger Thiele, Jaume Catala-Mora
Comprehensive Biology and Genetics Compendium of Wilms Tumor Cell Lines with Different WT1 Mutations. Cancers 13 (1) (2020)
Benjamin H Durham, Estibaliz Lopez Rodrigo, Jennifer L Picarsic, David Abramson, Veronica Rotemberg, Steven De Munck, Erwin Pannecoucke, Sydney X Lu, Alessandro Pastore, Akihide Yoshimi, Diana Mandelker, Ozge Ceyhan-Birsoy, Gary A Ulaner, Michael Walsh, Mariko Yabe, Kseniya Petrova-Drus, Maria E Arcila, Marc Ladanyi, David B Solit, Michael F Berger, David M Hyman, Mario E Lacouture, Caroline Erickson, Ruth Saganty, Michelle Ki, Ira J Dunkel, Vicente Santa-María López, Jaume Catala-Mora, Julien Haroche, Jean François Emile, Olivier Decaux, Frederic Geissmann, Savvas N Savvides, Alexander E Drilon, Eli L Diamond, Omar Abdel-Wahab
Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms. Nature medicine 25 (12) (2019)
Jaume Catala-Mora, S Perez-Jaume, O Cruz
Treatment of childhood astrocytomas with irinotecan and cisplatin. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20 (4) (2017)
Faizaan Mohammad, Simon Weissmann, Benjamin Leblanc, Deo P Pandey, Jonas W Højfeldt, Itys Comet, Chunqin Zheng, Jens Vilstrup Johansen, Nicolas Rapin, Bo Torben Porse, Andrey Tvardovskiy, Ole Nørregaard Jensen, Nagore G Olaciregui, Cinzia Lavarino, Mariona Suñol, Carmen de Torres, Jaume Catala-Mora, Angel M Carcaboso, Kristian Helin
EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas. Nature medicine 23 (4) (2017)